Company Filing History:
Years Active: 1998-1999
Title: Thomas Haemmerle: Innovating Genomic DNA Quantification Techniques
Introduction:
In the world of molecular biology, Thomas Haemmerle, based in Orth/Donau, AT, has made significant contributions to the field of nucleic acid quantification. With a deep understanding of genetic analysis methods, Haemmerle has patented groundbreaking techniques for accurately quantitating genomic DNA. Alongside his role at Immuno Aktiengesellschaft, Haemmerle's work has garnered attention for its precision and reproducibility.
Latest Patents:
Haemmerle's recent patents elucidate his expertise in quantitating genomic DNA and nucleic acids within a sample. The first patent (Method of quantitating genomic DNA) involves introducing an internal standard nucleic acid, distinct from the genomic DNA being analyzed, into the sample. By amplifying both the genomic DNA and the internal standard nucleic acid, using primers complementary to repetitive genomic sequences, Haemmerle can determine the original amount of genomic DNA present in the sample. This innovative method has paved the way for accurate quantitation of genomic DNA in a wide range of applications.
The second patent (Method of quantitating nucleic acid) expands upon the earlier method by incorporating multiple internal standard nucleic acids. By employing two or more internal standard nucleic acids that differ from each other and the nucleic acid being quantitated, Haemmerle achieves enhanced precision and reproducibility in the quantification process. This advancement enables scientists to obtain highly accurate nucleic acid quantification results, crucial for various research and diagnostic purposes.
Career Highlights:
Thomas Haemmerle's pioneering work in nucleic acid quantitation has placed him at the forefront of the field. Through his research and expertise, he has significantly contributed to the development of robust quantification techniques, leading to advancements in molecular biology and genetics research. Haemmerle's dedication to precision and reproducibility has made him a sought-after expert in the scientific community.
Collaborations:
Within the professional realm, Haemmerle has collaborated with esteemed colleagues such as Falko-Guenter Falkner and Michele Himmelspach. These collaborations have generated valuable insights and exchange of ideas, further enhancing the quality and impact of Haemmerle's work. By actively engaging in collaborative efforts, Haemmerle has expanded his research network and fostered a culture of innovation within his domain.
Conclusion:
Thomas Haemmerle's patents and contributions in the field of genomic DNA quantification stand as testament to his expertise and dedication to advancing scientific knowledge. His innovative methods for quantitating genomic DNA and nucleic acids have improved the accuracy and reliability of these analyses. Through collaborations and his role at Immuno Aktiengesellschaft, Haemmerle continues to make valuable contributions to the field of molecular biology, driving advancements in genetic research and diagnostic applications.